Market Cap

UCB SA Market Capitalization:

€26.88 Billion

EUR as of July 1, 2024

US$28.87 Billion

business UCB SA Company Profile

UCB SA Main Stock Listing

Euronext: UCB

Market Capitalization History of UCB SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of UCB SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €15.47 B 5.52%
Jan. 1, 2023 €14.66 B -13.20%
Jan. 1, 2022 €16.89 B 2.92%
Jan. 1, 2021 €16.41 B 2.94%
Jan. 1, 2020 €15.94 B 9.84%
Jan. 1, 2019 €14.51 B 7.75%
Jan. 1, 2018 €13.47 B 10.17%
Jan. 1, 2017 €12.22 B -18.95%
Jan. 1, 2016 €15.08 B 13.99%
Jan. 1, 2015 €13.23 B 31.40%
Jan. 1, 2014 €10.07 B 23.46%
Jan. 1, 2013 €8.16 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

UCB SA Categories

Belgium languages Healthcare languages Biotechnology
Belgium Healthcare Belgium Biotechnology

Stocks & Indices

UCB SA has the following listings and related stock indices.


Stock: Euronext: UCB

Stock: FSX: UNC

Stock: FSX: UNC0

Stock: OTC: UCBJY

Stock: OTC: UCBJF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.